The "2024-2030 China Intravenous Indwelling Needle Industry Market Status Analysis and Future Prospect Planning Report" (hereinafter referred to as the "Report") compiled by Zhiyan Consulting is a professional market research report in the field of intravenous indwelling needles in China, and is a faithful recorder and witness of the development of the intravenous indwelling needle industry. It aims to provide a comprehensive reference for Chinese intravenous indwelling needle industry manufacturers, government agencies, and industry experts to understand and grasp the development of intravenous indwelling needles in China.
The report has been published annually since 2018 and has been published for seven consecutive years. The "Report" has a total of 12 chapters, from the global status quo, market environment, industrial dynamics, import and export, operation situation, marketing strategy, competition pattern, development forecast, investment prospects and other aspects, through detailed data, comprehensively summarized and reviewed the new trends and new highlights of the intravenous indwelling needle industry in 2023, and at the same time carried out in-depth thinking on the existing problems. A series of useful suggestions and future prospects are put forward for the high-quality development of the intravenous indwelling needle industry in the next step.
The intravenous indwelling needle, also known as the intravenous cannula, is an infusion tool composed of a stainless steel puncture guide core, a soft outer cannula and a plastic needle holder, and is widely used in clinical practice as a replacement product for scalp needles. During the infusion process, the contact between the flexible tube of the indwelling needle and the blood vessel can effectively avoid vascular damage and reduce repeated venipuncture, thereby reducing the patient's pain and improving the efficiency of nursing work.
Indwelling needles have the advantages of simple operation, reducing patients' pain, ensuring rational drug use, facilitating infusion, and reducing nursing workload. Compared with scalp needles, indwelling needles have absolute advantages, representing the development direction of intravenous infusion, and will gradually replace scalp needles and become the mainstream puncture tool. With the rapid development of the mainland economy and the increase in financial investment in medical and health undertakings, many hospitals in the mainland have promoted the indwelling needle as a common nursing operation technology, and the indwelling needle is now widely accepted by people, and its market size and usage are increasing year by year. According to statistics, the global intravenous indwelling needle market size in 2023 will be 5.517 billion US dollars, and the Chinese intravenous indwelling needle market size will be 4.5 billion yuan, with a demand of 614 million.
The upstream of the intravenous indwelling needle industry chain is a supplier of raw materials and components, providing the raw materials required for the manufacture of intravenous indwelling needles, such as stainless steel (used to make needle cores), medical-grade plastics (used to make outer cannulas and needle sockets), etc. The midstream of the industrial chain is a manufacturer of intravenous indwelling needles, which is responsible for assembling the raw materials and parts provided by the upstream into complete intravenous indwelling needle products. These companies may have their own production lines or they may outsource their production. The downstream of the industrial chain are distributors and wholesalers (responsible for purchasing and selling IV indwelling needle products from manufacturers and selling them to medical institutions and other end users), medical institutions (including hospitals, clinics, community health service centers, etc., which are the main users of IV indwelling needles), and patients (end users, who receive medical services related to IV indwelling needles through medical institutions).
Domestic intravenous indwelling needle manufacturers mainly include Weigao Co., Ltd., Linhua Medical, Jiangxi Huali, Camel Group, Ande Medical, Sanxin Medical, Shengguang Medical Products, Shanghai Kangge, Baihe Medical, Shanghai Jinze, etc. Among them, Weigao Co., Ltd. is mainly engaged in R&D and development, production and sales of disposable medical devices. The main products include positive pressure closed indwelling needle, needle retractable intravenous indwelling needle, syringe retractable polyurethane intravenous indwelling needle, and disposable intravenous indwelling needle-type I. In 2023, the company's revenue will be 942 million yuan, a year-on-year increase of 15.59%, of which the revenue of indwelling needle business will be 699 million yuan, a year-on-year increase of 15.92%. Sanxin medical products are divided into three categories: blood purification, infusion and cardiothoracic surgery. In 2023, the company's newly certified disposable dialysis indwelling needle will be the first domestic product, breaking the import monopoly and having a leading advantage in the market.
The research team of Zhiyan Consulting conducted an in-depth analysis on the scale, industrial structure, key enterprises, and industrial development trends of China's intravenous indwelling needle industry, and put forward suggestions on the problems existing in the development of the intravenous indwelling needle industry, so as to provide reference for local governments, industrial chain related enterprises, and investment institutions.
Data Description:
1: The core data of this report has been updated to December 2023 (the relevant financial indicators of non-listed companies in the report are affected by corporate credit approval, and there may be a certain lag), and the forecast period of the report is 2024-2030.
2: In addition to the first-hand research information and data, authoritative data sources such as the National Bureau of Statistics, China Customs, industry associations, and public reports of listed companies (prospectuses, transfer prospectuses, annual reports, inquiry reports, etc.) also constitute the data sources of this report. The first-hand data comes from the first-hand information data obtained by the research team from interviews with key enterprises in the industry, and the main interview subjects include corporate executives, industry experts, technical leaders, downstream customers, distributors, agents, distributors and upstream raw material suppliers. Secondary sources mainly include relevant industry news, company annual reports, non-profit organizations, industry associations, government agencies and third-party databases from around the world.
3: The core data of the report is based on the strict data collection, screening, processing, analysis system and independent calculation model of the Zhiyan team to ensure the accuracy and reliability of statistical data.
4: The data used in this report are all from compliance channels, and the analysis logic is based on the professional understanding of the Zhiyan team, which clearly and accurately reflects the research views of analysts.
As a leading brand in the field of industrial consulting in China, Zhiyan Consulting takes "driving industrial development with information and empowering enterprise investment decision-making" as its brand concept. The company integrates quantitative analysis and qualitative analysis methods, uses self-developed algorithms, combines industry cross-big data, and excavates the root causes behind quantitative data through diversified analysis, analyzes the logic behind qualitative content, objectively and truthfully explains the current situation of the industry, prudently predicts the future development trend of the industry, and provides customers with professional industry analysis, market research, data insights, strategic consulting and related solutions to help customers improve their cognitive level, profitability and comprehensive competitiveness. The main services include high-quality industry research reports, special customization, monthly topics, feasibility study reports, business plans, industrial planning, etc. Provide weekly/monthly/quarterly/annual reports and other regular reports and customized data, covering policy monitoring, corporate dynamics, industry data, product price changes, investment and financing overview, market opportunities and risk analysis, etc.